BC Hepatitis Testers Cohort

Faculty of MedicineBC Hepatitis Testers Cohort | UBC Centre for Disease Control

Differing Profiles of People Diagnosed with Acute & Chronic Hepatitis B Virus in BC
In this study, we describe the characteristics of individuals diagnosed with acute and chronic HBV infections and identify the factors associated with HBV infection within the BC Hepatitis Testers Cohort (BC-HTC). We are unaware of any study comparing large population level data for both acute and chronic HBV. Study findings should inform prevention and […] Read More
Hepatitis C Cascade of Care in BC, 2020
Integration of various data sources enables HCV monitoring across the care cascade to assess program effectiveness. The majority of anti-HCV positive individuals were tested for RNA and genotyping. Very small proportion of HCV infected individuals received treatment. People with HIV coinfection and drug use despite being in liver care were less likely to receive treatment. […] Read More
Twin Epidemics of Hepatitis C in Canada
We characterized the twin epidemics of new and prevalent hepatitis C virus (HCV) infections in British Columbia, Canada to inform prevention, care and treatment programs. Read More
BC Hepatitis Testers Cohort
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants “The British Columbia (BC) Hepatitis Testers Cohort (BC-HTC) was established to assess and monitor hepatitis C (HCV) epidemiology, cost of illness and treatment effectiveness in BC, Canada. In this paper, we describe […] Read More

The British Columbia Hepatitis Testers Cohort (BC-HTC) is a dynamic cohort including all individuals who were tested for hepatitis C or HIV, or diagnosed with, hepatitis B, hepatitis C, HIV or active tuberculosis since 1990. These data are linked with corresponding data on medical visits, hospitalizations, cancers, prescription drugs, and death records. Various datasets in the BC-HTC data are updated on 6 months to biannual basis.

The overall purpose of the BC-HTC is to monitor disease burden related to hepatitis and associated infections and social conditions, evaluate impact of interventions, and monitor hepatitis program progress to inform policy and programming in British Columbia and Canada.

HIGHLIGHTS

RECENT PUBLICATIONS

JAN 2019 Hepatology Communications Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People who inject drugs and/or those in Opioid Agonist Therapy

DEC 2018 Canadian Liver J Contextualizing Canada’s hepatitis C virus epidemic

NOV 2018 J of Viral Hepatitis Applying core therapy and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia Canada

NOV 2018 Eclinical Medicine Syndemic chrachterizations of HCV, HBV, and HIV co-infections in a large population based cohort study

JUL 2018 J of Viral Hepatitis Estimating the imopact if early hepatitis C virus clearance in hepatocellulr carcinoma risk

AUG 2018 Dove Press Effect of opioid-subsitution therapy and mental health counseling on HIV risk among hepatitis C infected individuals

AUG 2018 J of Hepatol Hepatitis C virus after successful treatment with direct-acting antiviral therapy in a large population based cohort

MAR 2018 World J of Gastroenterology Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia

FEB 2018 Int J of drug policy Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets

NEWS

July 2018 Optimal strategies for the diagnoses and treatment of acute or chronic hepatitis B infection in British Columbia

February 2018 Canadian Liver Meeting- Poster of Distinction)

October 2017 New research underlines need to develop a hepatitis C vaccine

September 2017 Fast Facts: Hepatitis C treatment cascade and development in access to treatment

August 2017 The availability of direct –acting antivirals is reducing disparities in the uptake of hepatitis C treatment

August 2017 Previously Cured HCV patients can be reinfected-prevention will require attention to high-risk behaviours